top of page
Open Book


Decoys cover STM.gif
Screen Shot 2021-01-20 at 9.46.17 PM.png

*corresponding authors; ** these authors have contributed equally to the work​

(1)        Schnoor, B.; Morris, K.; Kottana, R. K.; Muldoon, R.; Barron, J.; Papa*, A.-L. Fibrinolytic Platelet Decoys Reduce Cancer Metastasis by Dissociating Circulating Tumor Cell Clusters. Advanced Healthcare Materials, 2024, accepted.

(2)        Kottana**, R. K.; Schnoor**, B.; Papa*, A.-L. A Method to Quantitatively Characterize the Formation and Dissociation of Tumor Cell Clusters Using Light Transmission Aggregometry. Molecular Oncology, 2024, accepted.

(3)        Morris**, K.; Schnoor**, B.; Papa*, A.-L. Platelet Cancer Cell Interplay as a New Therapeutic Target. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022, 1877 (5), 188770.

(4)        Schnoor, B.; Papa*, A.-L. Lyophilized Platelets Inhibit Platelet Aggregation with Simultaneous Paradoxical Promotion of Platelet Adhesion. Front. Bioeng. Biotechnol. 2022, 10, 941817.

(5)        Bilynsky, C.; Millot, N.; Papa*, A. Radiation Nanosensitizers in Cancer Therapy—From Preclinical Discoveries to the Outcomes of Early Clinical Trials. Bioengineering & Transla Med 2022, 7 (1).

(6)        Kottana, R. K.; Maurizi, L.; Schnoor, B.; Morris, K.; Webb, J. A.; Massiah, M. A.; Millot, N.; Papa*, A. Anti‐Platelet Effect Induced by Iron Oxide Nanoparticles: Correlation with Conformational Change in Fibrinogen. Small 2020, 2004945.

(7)        Papa*, A.-L.; Jiang, A.; Korin, N.; Chen, M. B.; Langan, E. T.; Waterhouse, A.; Nash, E.; Caroff, J.; Graveline, A.; Vernet, A.; Mammoto, A.; Mammoto, T.; Jain, A.; Kamm, R. D.; Gounis, M. J.; Ingber*, D. E. Platelet Decoys Inhibit Thrombosis and Prevent Metastatic Tumor Formation in Preclinical Models. Sci Transl Med 2019, 11 (479).

(8)        Papa, A.-L.; Korin, N.; Kanapathipillai, M.; Mammoto, A.; Mammoto, T.; Jiang, A.; Mannix, R.; Uzun, O.; Johnson, C.; Bhatta, D.; Cuneo, G.; Ingber*, D. E. Ultrasound-Sensitive Nanoparticle Aggregates for Targeted Drug Delivery. Biomaterials 2017, 139, 187–194.

(9)        Jain, A.; van der Meer, A. D.; Papa, A.-L.; Barrile, R.; Lai, A.; Schlechter, B. L.; Otieno, M. A.; Louden, C. S.; Hamilton, G. A.; Michelson, A. D.; Frelinger, A. L.; Ingber*, D. E. Assessment of Whole Blood Thrombosis in a Microfluidic Device Lined by Fixed Human Endothelium. Biomed Microdevices 2016, 18 (4), 73.

(10)     Papa, A.-L.; Boudon, J.; Bellat, V.; Loiseau, A.; Bisht, H.; Sallem, F.; Chassagnon, R.; Bérard, V.; Millot*, N. Dispersion of Titanate Nanotubes for Nanomedicine: Comparison of PEI and PEG Nanohybrids. Dalton Trans 2015, 44 (2), 739–746.

(11)     Maurizi, L.; Papa, A.-L.; Dumont, L.; Bouyer, F.; Walker, P.; Vandroux, D.; Millot*, N. Influence of Surface Charge and Polymer Coating on Internalization and Biodistribution of Polyethylene Glycol-Modified Iron Oxide Nanoparticles. j biomed nanotechnol 2015, 11 (1), 126–136.

(12)     Marosfoi, M. G.; Korin, N.; Gounis, M. J.; Uzun, O.; Vedantham, S.; Langan, E. T.; Papa, A.-L.; Brooks, O. W.; Johnson, C.; Puri, A. S.; Bhatta, D.; Kanapathipillai, M.; Bronstein, B. R.; Chueh, J.-Y.; Ingber*, D. E.; Wakhloo*, A. K. Shear-Activated Nanoparticle Aggregates Combined With Temporary Endovascular Bypass to Treat Large Vessel Occlusion. Stroke 2015, 46 (12), 3507–3513.

(13)     Pandey, A.; Sarangi, S.; Chien, K.; Sengupta, P.; Papa, A.-L.; Basu, S.; Sengupta*, S. Anti-Platelet Agents Augment Cisplatin Nanoparticle Cytotoxicity by Enhancing Tumor Vasculature Permeability and Drug Delivery. Nanotechnology 2014, 25 (44), 445101.

(14)     Sarangi, S.; Pandey, A.; Papa, A.-L.; Sengupta, P.; Kopparam, J.; Dadwal, U.; Basu, S.; Sengupta*, S. P2Y12 Receptor Inhibition Augments Cytotoxic Effects of Cisplatin in Breast Cancer. Med. Oncol. 2013, 30 (2), 567.

(15)     Papa, A.-L.; Sidiqui, A.; Balasubramanian, S. U. A.; Sarangi, S.; Luchette, M.; Sengupta, S.; Harfouche*, R. PEGylated Liposomal Gemcitabine: Insights into a Potential Breast Cancer Therapeutic. Cell Oncol (Dordr) 2013, 36 (6), 449–457.

(16)     Papa, A.-L.; Dumont, L.; Vandroux, D.; Millot*, N. Titanate Nanotubes: Towards a Novel and Safer Nanovector for Cardiomyocytes. Nanotoxicology 2013, 7 (6), 1131–1142.

(17)     Mirjolet, C.; Papa, A. L.; Créhange, G.; Raguin, O.; Seignez, C.; Paul, C.; Truc, G.; Maingon, P.; Millot*, N. The Radiosensitization Effect of Titanate Nanotubes as a New Tool in Radiation Therapy for Glioblastoma: A Proof-of-Concept. Radiother Oncol 2013, 108 (1), 136–142.

(18)     Paraskar, A.; Soni, S.; Roy, B.; Papa, A.-L.; Sengupta*, S. Rationally Designed Oxaliplatin-Nanoparticle for Enhanced Antitumor Efficacy. Nanotechnology 2012, 23 (7), 075103.

(19)     Papa, A.-L.; Basu, S.; Sengupta, P.; Banerjee, D.; Sengupta, S.; Harfouche*, R. Mechanistic Studies of Gemcitabine-Loaded Nanoplatforms in Resistant Pancreatic Cancer Cells. BMC Cancer 2012, 12, 419.

(20)     Papa, A.-L.; Maurizi, L.; Vandroux, D.; Walker, P.; Millot*, N. Synthesis of Titanate Nanotubes Directly Coated with USPIO in Hydrothermal Conditions: A New Detectable Nanocarrier. J. Phys. Chem. C 2011, 115 (39), 19012–19017.

(21)     Papa, A.-L.; Millot*, N.; Saviot, L.; Chassagnon, R.; Heintz, O. Effect of Reaction Parameters on Composition and Morphology of Titanate Nanomaterials. J. Phys. Chem. C 2009, 113 (29), 12682–12689.

(22)     Saviot*, L.; Netting, C. H.; Murray, D. B.; Rols, S.; Mermet, A.; Papa, A.-L.; Pighini, C.; Aymes, D.; Millot, N. Inelastic Neutron Scattering Due to Acoustic Vibrations Confined in Nanoparticles: Theory and Experiment. Phys. Rev. B 2008, 78 (24), 245426.

Book Chapters

(1)     Maurizi L, Papa AL, Boudon J, Sudhakaran S, Pruvot B, Vandroux D, Chluba J, Lizard G, Millot N. Toxicological Risk Assessment of Emerging Nanomaterials: Cytotoxicity, Cellular Uptake, Effects on Biogenesis and Cell Organelle Activity, Acute Toxicity and Biodistribution of Oxide Nanoparticles. Unraveling the Safety Profile of Nanoscale Particles and Materials-From Biomedical to Environmental Applications. 2018;InTech.

(2)     Boudon J, Papa A-L, Paris J, Millot N. Titanate nanotubes as a versatile platform for nanomedicine. Nanomedicine. 2014;One Central Press:404-29.

(3)     Boudon J, Sallem F, Loiseau A, Maurizi L, Papa A.-L., Millot N, Development of novel versatile theranostic platforms based on titanate nanotubes: towards safe nanocarriers for biomedical applications, 2021.

bottom of page